MCJ : A mitochondrial target for cardiac intervention in pulmonary hypertension
Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Science advances - 10(2024), 3 vom: 19. Jan., Seite eadk6524 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Santamans, Ayelén M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.02.2024 Date Revised 01.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1126/sciadv.adk6524 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367318709 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367318709 | ||
| 003 | DE-627 | ||
| 005 | 20240201232148.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240120s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1126/sciadv.adk6524 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1277.xml |
| 035 | |a (DE-627)NLM367318709 | ||
| 035 | |a (NLM)38241373 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Santamans, Ayelén M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MCJ |b A mitochondrial target for cardiac intervention in pulmonary hypertension |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.02.2024 | ||
| 500 | |a Date Revised 01.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Mcj protein, mouse |2 NLM | |
| 700 | 1 | |a Cicuéndez, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Mora, Alfonso |e verfasserin |4 aut | |
| 700 | 1 | |a Villalba-Orero, María |e verfasserin |4 aut | |
| 700 | 1 | |a Rajlic, Sanela |e verfasserin |4 aut | |
| 700 | 1 | |a Crespo, María |e verfasserin |4 aut | |
| 700 | 1 | |a Vo, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Jerome, Madison |e verfasserin |4 aut | |
| 700 | 1 | |a Macías, Álvaro |e verfasserin |4 aut | |
| 700 | 1 | |a López, Juan Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Leiva, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Rocha, Susana F |e verfasserin |4 aut | |
| 700 | 1 | |a León, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Leiva, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Pintor Chocano, Aránzazu |e verfasserin |4 aut | |
| 700 | 1 | |a García Lunar, Inés |e verfasserin |4 aut | |
| 700 | 1 | |a García-Álvarez, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Hernansanz-Agustín, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a Peinado, Víctor I |e verfasserin |4 aut | |
| 700 | 1 | |a Barberá, Joan Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Ibañez, Borja |e verfasserin |4 aut | |
| 700 | 1 | |a Vázquez, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Spinelli, Jessica B |e verfasserin |4 aut | |
| 700 | 1 | |a Daiber, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Oliver, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Sabio, Guadalupe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Science advances |d 2015 |g 10(2024), 3 vom: 19. Jan., Seite eadk6524 |w (DE-627)NLM247717614 |x 2375-2548 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:3 |g day:19 |g month:01 |g pages:eadk6524 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1126/sciadv.adk6524 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 3 |b 19 |c 01 |h eadk6524 | ||